Dr. Martens plc (DOCS.L)
London, GB
Dr. Martens plc is a global footwear enterprise that handles the entire process of conceiving, crafting, sourcing materials for, marketing, selling, and distributing its products. The company boasts a significant international presence, serving customers across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific region. Its extensive product range includes classic 'Originals' footwear, contemporary 'fusion' styles, children's shoes, and casual designs, alongside various accessories. All merchandise is offered exclusively under the renowned Dr. Martens brand. Established in 1945, Dr. Martens plc maintains its corporate headquarters in London, United Kingdom.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.68% | +2.35% | +18.97% | +6.78% | -4.27% | -3.39% | +24.16% | -51.67% | -85.14% | -83.56% | -83.56% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Apparel - Footwear & Accessories: +5.0%-2.9% Q1'26: -8.0% (vs Q1'24)
-
EPS growth Apparel - Footwear & Accessories: +5.0%+386.0% ★ Q1'26: -33.2% (vs Q1'24)
-
FCF margin FCF growth · Apparel - Footwear & Accessories: +7.7%+15.6% Q1'26: +30.8% (vs Q1'24)
-
EBIT margin Apparel - Footwear & Accessories: +8.8%+10.0% ★ Q1'26: +16.6% (vs Q1'24)
-
ROIC Apparel - Footwear & Accessories: +7.3%+9.7% ★ Q1'26: +39.6% (vs Q1'24)
-
Share dilution Apparel - Footwear & Accessories: +0.0%+0.6% Q1'26: +0.8% (vs Q1'24)
-
Debt / EBITDA Net debt/EBITDA · Apparel - Footwear & Accessories: -0.25×2.70× Q1'26: 0.91× (vs Q1'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 5 Rev. Ana. 6 EPS Ana. |
Mar 2027 4 Rev. Ana. 5 EPS Ana. |
Mar 2028 5 Rev. Ana. 4 EPS Ana. |
Mar 2029 5 Rev. Ana. 2 EPS Ana. |
Mar 2030 2 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
773.00M
est: 769.27M (+0.5%)
|
908.30M
est: 905.59M (+0.3%)
|
1.00B
est: 999.13M (+0.1%)
|
877.10M
est: 887.98M (-1.2%)
|
787.60M
est: 795.70M (-1.0%)
|
769.68M
761.50M – 777.39M
-3.3% YoY
|
787.68M
769.66M – 797.14M
+2.3% YoY
|
826.06M
806.40M – 850.60M
+4.9% YoY
|
861.96M
859.17M – 864.76M
+4.3% YoY
|
916.60M
895.20M – 935.95M
+6.3% YoY
|
971.60M
948.92M – 992.11M
+6.0% YoY
|
| EBITDA |
143.30M
est: 165.59M (-13.5%)
|
265.10M
est: 194.93M (+36.0%)
|
235.00M
est: 215.07M (+9.3%)
|
196.30M
est: 191.14M (+2.7%)
|
110.50M
est: 171.94M (-35.7%)
|
166.32M
164.56M – 167.99M
-3.3% YoY
|
170.21M
166.32M – 172.26M
+2.3% YoY
|
178.51M
174.26M – 183.81M
+4.9% YoY
|
186.26M
185.66M – 186.87M
+4.3% YoY
|
198.07M
193.45M – 202.25M
+6.3% YoY
|
209.96M
205.05M – 214.39M
+6.0% YoY
|
| EBIT |
108.40M
est: 117.47M (-7.7%)
|
228.20M
est: 138.28M (+65.0%)
|
176.90M
est: 152.56M (+16.0%)
|
124.00M
est: 135.59M (-8.5%)
|
38.00M
est: 114.83M (-66.9%)
|
111.08M
109.90M – 112.19M
-3.3% YoY
|
113.67M
111.07M – 115.04M
+2.3% YoY
|
119.21M
116.38M – 122.75M
+4.9% YoY
|
124.40M
123.99M – 124.80M
+4.3% YoY
|
132.28M
129.19M – 135.07M
+6.3% YoY
|
140.22M
136.94M – 143.18M
+6.0% YoY
|
| Net Income |
34.70M
est: 105.17M (-67.0%)
|
181.20M
est: 150.65M (+20.3%)
|
128.90M
est: 136.30M (-5.4%)
|
69.20M
est: 69.20M (+0.0%)
|
4.50M
est: 25.02M (-82.0%)
|
38.05M
37.31M – 38.79M
+52.1% YoY
|
48.65M
45.12M – 52.83M
+27.9% YoY
|
60.93M
57.51M – 65.47M
+25.2% YoY
|
71.80M
66.44M – 75.11M
+17.8% YoY
|
85.23M
82.64M – 87.56M
+18.7% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
240.00M
est: 236.31M (+1.6%)
|
309.40M
est: 278.18M (+11.2%)
|
373.10M
est: 306.92M (+21.6%)
|
448.80M
est: 272.77M (+64.5%)
|
100.0K
est: 270.12M (-100.0%)
|
261.29M
258.51M – 263.91M
-3.3% YoY
|
267.40M
261.28M – 270.61M
+2.3% YoY
|
280.43M
273.76M – 288.76M
+4.9% YoY
|
292.62M
291.67M – 293.57M
+4.3% YoY
|
311.17M
303.90M – 317.73M
+6.3% YoY
|
329.84M
322.14M – 336.80M
+6.0% YoY
|
| EPS |
0.03
est: 0.11 (-67.9%)
|
0.18
est: 0.15 (+16.4%)
|
0.13
est: 0.14 (-7.1%)
|
0.07
est: 0.07 (-5.2%)
|
0.01
est: 0.03 (-80.4%)
|
0.04
0.04 – 0.04
+52.0% YoY
|
0.05
0.05 – 0.05
+29.8% YoY
|
0.06
0.06 – 0.07
+23.2% YoY
|
0.07
0.07 – 0.08
+16.2% YoY
|
0.09
0.08 – 0.09
+20.4% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-19 | B- | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-18 | B- | 3/5 | 5/5 | 3/5 | 3/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-15 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-14 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-13 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-05 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-01 | B- | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | B- | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | B- | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | B- | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | B- | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | B- | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | B- | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | B- | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | B- | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | B- | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | B- | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | B- | 3/5 | 5/5 | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Europe SmallCap Dividend UCITS ETF Acc DFEA.L | 0.19% | 178.9K | 0.38% |
| 2 | WisdomTree Europe SmallCap Dividend UCITS ETF WTES.DE | 0.19% | 178.9K | 0.38% |
| 3 | Invesco FTSE 250 UCITS ETF S250.L | 0.14% | 48.7K | 0.12% |
| 4 | Vanguard FTSE 250 UCITS ETF VMIG.MI | 0.14% | 3.63M | 0.10% |
| 5 | Vanguard FTSE 250 UCITS ETF (GBP) Distributing VMID.DE | 0.14% | 3.63M | 0.10% |
| 6 | Xtrackers FTSE 250 UCITS ETF 1D XMCX.L | 0.14% | 52.5K | 0.15% |
| 7 | HSBC FTSE 250 UCITS ETF HMCX.L | 0.13% | 91.0K | 0.09% |
| 8 | iShares FTSE 250 UCITS ETF MIDD.L | 0.13% | 1.12M | 0.40% |
| 9 | iShares MSCI United Kingdom Small-Cap ETF EWUS | 0.12% | 48.8K | 0.59% |
| 10 | iShares MSCI UK Small Cap UCITS ETF CUKS.L | 0.12% | 152.5K | 0.58% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Giles Robert Bryant Wilson | Chief Financial Officer & Director | 2M | male |
| Onyeije Ogueri Nwokorie | Chief Executive Officer & Executive Director | 303.0K | male |
| Bridget Jolliffe | Chief People Officer | — | female |
| Derek Chan | President of APAC | — | male |
| Geert Peeters | Chief Operating Officer | — | male |
| Graham Calder | Chief Technology Officer | — | — |
| Jennifer Somer | President of Americas | — | female |
| Mike Stopforth | President of EMEA | — | male |
| Adam Meek | Chief Product Officer | — | male |
| Sean O'Neill | Chief Digital Officer | — | male |
| Bethany Barnes | Director of Investor Relations & Corporate Communications | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DOCS.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
